Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

This review discusses the epidemiology, burden and pathogenesis of dengue, as well as the vaccine candidates currently in clinical development. There is, therefore, an urgent unmet need for a safe ...

Dengue fever is a common tropical infection. This acute febrile illness can be a deadly infection in cases of severe manifestation, causing dengue hemorrhagic shock. In this brief article, I will ...

Dengue fever is caused by an arthropod-borne flavivirus and usually presents as a self-limiting febrile illness, but in more severe cases, a high fever, hemorrhaging, and plasma leakage can occur.

doi:10.1172/JCI21512 Stephenson, J. R. Understanding dengue pathogenesis: Implications for vaccine design. Bulletin of the World Health Organization 83, 308–314 (2005) doi:10.1590/S0042 ...

Dengue viral infections can result in a range of symptoms. Some people show no symptoms or just have mild signs of the disease, but others develop severe complications. How does the body respond ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...

Researchers have uncovered how the dengue virus uses its envelope protein to hijack human plasmin to enhance transmission.